| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $157K | -45.4% |
| Cost of Revenue | $45K | -79.3% |
| R&D Expense | $362K | -55.0% |
| SG&A Expense | $544K | -49.0% |
| Interest Expense | $229K | +205.0% |
| Pre-tax Income | -$2.0M | +49.9% |
| Income Tax | $0 | — |
| Net Income | -$2.0M | +49.9% |
| EPS (Basic) | -$0.01 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $193K | +200.7% |
| Current Assets | $225K | +179.2% |
| Total Assets | $1.6M | -0.3% |
| Current Liabilities | $3.7M | +32.0% |
| Total Liabilities | $3.7M | +31.5% |
| Stockholders' Equity | -$2.2M | -70.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +47.2% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $1.4M | -45.6% |
| +66.7% |
| EPS (Diluted) | -$0.01 | +66.7% |